Objectives, Etiology, Epidemiology, Pathophysiology, Histopathology, Diagnosis, Differential Diagnosis, Treatment and Prognosis of Vulva Cancer

In the US, vulvar cancer accounts for 0.3% of all new cancer cases. The most prevalent kind, squamous cell carcinoma, is often identified between the ages of 65 and 74. An examples for Risk factors are enhancing age, HPV infection, smoking, inflammatory conditions of the vulva, prior pelvic radiation, and immunodeficiency. It generally presents as an erythematous lesion or an ill-defined mass. Diagnosis is usually executed dependent upon tissue biopsy, with surgical excision being the mainstay of treatment. Adjuvant chemo and radiotherapy can also be taken into consideration depending on the stage of the disease. This activity explains about the evaluation and management of vulvar Cancer and highlights the healthcare team's role in diagnosing and treating patients with vulvar cancer.